Abstract A decrease in the myocardial level of the mRNA encoding the Ca2+-ATPase of the sarcoplasmic reticulum (SR) has been recently reported during experimental cardiac hypertrophy and failure. To determine if such a deficit occurs in human endstage heart failure, we compared the SR Ca2+-ATPase mRNA levels in left (LV) and right ventricular (RV) specimens from 13 patients undergoing cardiac transplantation (6 idiopathic dilated cardiomyopathies; 4 coronary artery diseases with myocardial infarctions; 3 diverse etiologies) with control heart samples using a rat cardiac SR Ca2+-ATPase cDNA probe. We observed a marked decrease in the mRNA for the Ca2+-ATPase relative to both the 18S ribosomal RNA and the myosin heavy chain mRNA in LV specimens of patients with heart failure compared to controls (-48%, P < 0.01 and -47%, P < 0.05, respectively). The LV ratio of Ca2+-ATPase mRNA to 18S RNA positively correlated with cardiac index (P < 0.02).
Introduction
A number of studies have emphasized the importance ofalterations in myocardial relaxation that occur during cardiac hypertrophy and failure. Such alterations have been reported in several animal models, and in man they are associated with the pathophysiology of most cardiac diseases such as ischemic heart disease and idiopathic dilated or hypertrophic cardiomyopathies (reviewed in 1). Myocardial relaxation is governed by multiple factors but defects in calcium (Ca2+) movements within the cardiac myocyte seem to play a central role in italterations. In the failing human myocardium, as in hypertrophied ferret ventricles, prolonged relaxation appears to correlate with changes in intracellular Ca2" handling (2, 3). Furthermore in hypertrophied rabbit ventricles, the tension independent heat of the contraction-relaxation cycle, which has been attributed to the energy cost of Ca2+ movements, is depressed (4) . Ca2+ movements during relaxation include dissociation from troponin C, extracellular extrusion through the sarcolemmal Ca2+ pump and sodium/calcium exchange, but is dominated by ATP dependent uptake by the sarcoplasmic reticulum (SR).' Most authors agree that the velocity of SR Ca2+ uptake is decreased during stable hypertrophy (reviewed in 5) and is further depressed during cardiac failure (6) . We and others have recently shown that in rat and rabbit, ventricular hypertrophy is associated with a decreased myocardial level of SR Ca2+-ATPase mRNA and an associated decrease in protein concentration (7) (8) (9) . This, at least in part, could be responsible for the slower velocity of Ca2+ uptake by the SR of these hearts and could account for a delayed rate of myocardial relaxation.
The purpose of the present study was to determine if there were similar changes associated with human heart failure. To answer this question, we have compared the relative levels of SR Ca2+-ATPase mRNA in left and right ventricular specimens from patients (NYHA class IV) undergoing cardiac transplantation with samples from control hearts obtained at the time of organ harvest.
Methods
Patients. Hearts from 6 patients without heart failure and 13 patients undergoing cardiac transplantation were investigated. The six patients without heart failure were accident victims maintained under intensive care as heart donor candidates but whose hearts were ultimately rejected for transplantation, for reasons other than depressed cardiac function. Main clinical characteristics ofthese six patients are summarized in Table I . Muscle specimens from this group are categorized in this report as controls (C). 13 patients underwent cardiac transplant surgery for chronic end-stage heart failure with the following diagnoses: six had idiopathic dilated cardiomyopathy (D), four had chronic coronary artery disease with at least one myocardial infarction (i), and the remaining three consisted of one partial atrioventricular canal (AVC), one mitral (MR) and one aortic regurgitation (AR). Relevant clinical, catheterization, and echocardiographic data from these pa-1. Abbreviations used in this paper: AR, aortic regurgitation; AVC, atrioventricular canal; C, control; D, dilated cardiomyopathy; HF, failing hearts; Li, liver; MHC, myosin heavy chain; MR, mitral regurgitation; SR, sarcoplasmic reticulum. Table II . Tissue specimens were obtained as apand 0.015 M sodium citrate), 50°C. Since in rat ventricular hyperproved by the committees for the protection of human subjects at the trophy, total RNA and mRNA vary in parallel (13), we used a 24 mer respective institutions.
synthetic oligonucleotide specific for the rat 18S ribosomal RNA (nuTissue preparation. Hearts were placed in ice-cooled saline immecleotides + 1046 to + 1070) as a control for the quantity ofRNA bound diately after removal and myocardial specimens gathered < 1 h after to the filters (14) . Filters were dehybridized and rehybridized with the explantation. A transmural specimen of -500 mg was taken from the 18S probe labeled at the 5' end with [ty-32P]ATP (Amersham Corp., medial part ofthe left ventricular free wall when possible, and midway Arlington Heights, IL) by T4 polynucleotide kinase (Boehringerbetween the apex and base, at least 2 cm away from the scar in patients Mannheim, Inc., Indianapolis, IN) and diluted with cold oligonucleowith myocardial infarctions. In 1 control and 11 transplanted hearts, a tide (1/400) to a specific activity of 1-2 X 106 dpm/ug. Hybridization right ventricular sample was also taken from the medial part of the conditions were the same as those used for the SR Ca2+-ATPase except right ventricular free wall. Immediately after sampling, myocardial that formamide was omitted and replaced by water. Washing condispecimens were blotted dry, frozen in liquid nitrogen, and stored at tions were 3X SSC at room temperature. 
Results
Specificity ofthe probes used. Northern blot analysis (Fig. 1 A) demonstrated that the probes hybridized as single sharp bands in both control (C) and failing (HF) hearts, showing that our RNAs were not degraded. The sizes of the Ca2+-ATPase and MHC mRNAs (-4 and 6.9 kb, respectively) were similar to those previously reported in rat and rabbit (8, 9, 12, 15) . Strong signals were also observed for both cardiac RNAs by dot blot analysis (Fig. 1 B) . By contrast, the signals obtained from rat liver RNA samples (Li) were very weak, indicating that our experimental conditions allowed unambiguous identification and quantification of human cardiac Ca2+-ATPase mRNA.
Ventricular Ca2?-A TPase mRNA levels. The ratio of Ca2+-ATPase mRNA to 18S RNA was 1.18±0.22 in control left ventricles and 0.61±0.06 in failing ones, which represents a decrease of 48% (P < 0.01, Fig. 2 ). The ratio of Ca2+-ATPase mRNA to MHC mRNA in the failing left ventricles was also markedly lower than that in controls (0.55±0.08 vs. 1.04±0.27, -47%, P < 0.05), indicating that in the failing human heart, Ca2+-ATPase mRNA decreased not only relative to total cardiac RNA, but also to myocyte specific RNA. The ratios in the right ventricles of the failing hearts were not statistically different from those in the left ventricles (0.76±0.11 and 0.56±0.04 for Ca2+-ATPase/l 8S and Ca2+-ATPase/MHC, respectively). We found no difference between patients with idiopathic dilated cardiomyopathies and those with coronary artery disease, in either the left or right ventricular Ca2+-ATPase mRNA/18S RNA. By contrast, we found significant correlations between both left or right ventricular Ca2+-ATPase mRNA to 18S RNA ratios and several indices of heart function. The left ventricular ratio correlated positively with cardiac index (r = 0.70, P < 0.02). The right ventricular ratio correlated with the systolic, diastolic and mean pulmonary arterial pressures (r = 0.74, P < 0.02; r = 0.73, P < 0.02; and r = 0.75, P < 0.01, respectively). Only the right ventricular Ca2+-ATPase/MHC correlated with cardiac index (r = 0.71, P < 0.05). No correlation was found between the Ca2+-ATPase mRNA to 18S RNA or MHC mRNA and any of the echocardiographic parameters or heart weight. 
Discussion
The alterations of systolic myocardial function, which clinically describe cardiac failure have been extensively studied, and changes in myocardial myosin phenotype, myofibrillar ATPase activity, and myofibrillar network density have been suggested as possible mechanisms for these alterations (17, 18). The molecular basis for the abnormal myocardial relaxation has been less well documented. However, a decrease in calcium reuptake by the SR from human failing hearts (reviewed in 5) and indirect proof for this decrease based on altered intracellular calcium movements have been described (2). We now report a decrease in the SR Ca2+-ATPase mRNA content as a first step in the elucidation of the molecular mechanisms of abnormal calcium handling during diastole in human heart failure.
The SR Ca2+-ATPase belongs to a multigene family with a single isoform analogous to that from slow skeletal muscle which is expressed in ventricular and atrial myocardium of rabbit, rat and man (8, 9, 11, (19) (20) (21) (22) . In rabbit and rat, the same isoform accumulates under the effects of an increased hemodynamic load (7) (8) (9) . This isoform is also expressed in the aorta and at low levels in other smooth muscle and nonmuscle tissues, which contain a different isoform identical to the slow skeletal/cardiac one except for an approximately 150 nucleotide addition at the 3' coding end and a different untranslated region (11, 12, 21, 22) . The hybridization of our probe to a single 4-kb band (Fig. 1 A) therefore reflects the presence of both slow skeletal/cardiac muscle and smooth/nonmuscle Ca2+-ATPase iso-mRNAs. However, we recently demonstrated by S 1 nuclease analysis that smooth/non-muscle Ca2+-ATPase iso-mRNA is barely detectable in normal and hypertrophied rat ventricles (7) . Moreover the hybridization signals obtained by Northern blot analysis with RNA isolated from human endothelial cells and rat smooth muscle tissues are respectively 200 and 50 times less than those obtained with similar amounts of RNA from rat ventricles (12, 23) . It therefore seems reasonable to assume that the Ca2+-ATPase mRNA hybridization signals obtained from normal and failing hearts originate primarily from hybridization to the slow skeletal/cardiac isoform of the SR Ca2+-ATPase. We observed a decrease in the SR Ca2+-ATPase mRNA content of failing ventricles relative to controls. This decrease is one of the first indices of human cardiac failure to correlate exactly with results from animal models of heart failure. In rat ventricular hypertrophy the decrease in SR Ca2+-ATPase mRNA content parallels a decrease in Ca2+-ATPase protein concentration, which suggests a decrease in SR Ca2+-ATPase pump density (7, 8) . One can hypothesize a similar relationship between the amount of mRNA and protein in human cardiac failure. Consequently, the low Ca2+-ATPase mRNA content that we have demonstrated here should be accompanied by a decrease of the Ca2+-ATPase protein concentration. Such a reduction in the number of SR Ca2+ pumps in failing human hearts may account for the prolonged Ca2+ transients and the depressed rate of Ca2+ uptake by SR vesicles (2, 5, 24).
The absence of any significant difference in Ca2+-ATPase mRNA/18S RNA between idiopathic dilated cardiomyopathic and infarcted myocardial samples suggests that this decrease is not related to a specific etiology. Indeed, we found a positive correlation between the left ventricular ratio and the cardiac index. We also found negative correlations between the right ventricular ratio and the systolic, diastolic, and mean pulmonary arterial pressures. These pressures, which gradually increase in the failing heart first as a result of elevated left ventricular filling pressures and then because of increased pulmonary vascular resistances (25) , are considered as a reflection of the severity and duration of the hemodynamic overload. The correlations that we have found suggest that the severity of myocardial hemodynamic overload is an important determinant of the Ca2+-ATPase mRNA content.
Chronic congestive heart failure is associated with an inability of the ventricular myocardium to generate sufficient force to ensure normal cardiac output and with reduced diastolic relaxation, which alters ventricular filling and further compromises cardiac function. Possible alterations in SR function that may result from the changes in Ca2+-ATPase mRNA accumulation reported here may be one of the pathophysiological mechanisms responsible not only for abnormal relaxation but also for altered contractility due to insufficient activation of myofibrillar proteins during systole. In this respect, the decrease in the ratio ofthe Ca2+-ATPase to the MHC mRNAs could indicate an imbalance between the contraction and relaxation abilities ofthe failing myocardium. Elucidation of the mechanisms responsible for this reduction in SR Ca2+-ATPase mRNA accumulation in the failing human ventricle is now required.
